grant

The Role of the Hippocampal Vasculature in Vascular Cognitive Impairment and Dementia

Organization STATE UNIVERSITY OF NY,BINGHAMTONLocation BINGHAMTON, UNITED STATESPosted 1 Apr 2022Deadline 31 Mar 2027
NIHUS FederalResearch GrantFY2026(TNF)-α21+ years oldAccelerationAdultAdult HumanAffectAgeAge MonthsAgingAmentiaAmmon HornAngIIAngiotensin IIArteriosclerotic DementiaAtrophicAtrophyBlood SerumBlood VesselsBlood capillariesBlood flowBrainBrain Hypoxia-IschemiaBrain Nervous SystemBrain VascularBrain Vascular DisordersBrain regionBuffersCNS plasticityCachectinCell Communication and SignalingCell SignalingCerebrovascular DiseaseCerebrovascular DisordersCerebrumChronicClinical ResearchClinical StudyCognitionCognitiveCognitive DisturbanceCognitive ImpairmentCognitive agingCognitive declineCognitive function abnormalCommon Rat StrainsCornu AmmonisDataDementiaDifferences between sexesDiffers between sexesDisturbance in cognitionDysfunctionEDN1ET-1EncephalonEndothelin Type 1Endothelin-1EndotheliumFemaleFunctional disorderGoalsHealthHippocampusHypertensionImpaired cognitionImpairmentIn VitroInbred SHR RatsIndividualInfarctionInjuryIntracellular Communication and SignalingIntracranial Vascular DiseasesIntracranial Vascular DisordersKnowledgeLearningLesionMacrophage-Derived TNFMeasuresMediatorMemoryMemory DeficitMemory LossMemory impairmentMetabolicMicrocirculationModelingMonocyte-Derived TNFMuscle functionNatureNerve CellsNerve UnitNeural CellNeurocognitiveNeurocyteNeuronal InjuryNeuronal PlasticityNeuronsNeurovascular dysfunctionOutcome StudyOxidative StressOxidative Stress Induced Gene Expression Via Nrf2Oxidative Stress PathwayPathogenesisPathologicPathway interactionsPatientsPerfusionPersonsPhysiopathologyPopulationPost-MenopausePost-menopausal PeriodPostmenopausal PeriodPostmenopausePredispositionPropertyPublishingRatRats MammalsRattusRestRiskRisk FactorsRoleSHR RatsSerumSex DifferencesSexual differencesSignal TransductionSignal Transduction SystemsSignalingSpontaneously Hypertensive RatsStructureSusceptibilityTNFTNF ATNF AlphaTNF geneTNF-αTNFATNFαTherapeuticTumor Necrosis FactorTumor Necrosis Factor-alphaVascular Cognitive ImpairmentVascular DementiaVascular Hypertensive DiseaseVascular Hypertensive DisorderVascular Smooth MuscleVasoactive AgonistsVasoconstrictor AgentsVasoconstrictor DrugsVasoconstrictorsVasodilatationVasodilationVasopressor AgentsVasorelaxationadulthoodafter menopauseagesarteriolebiological signal transductionbrain microvasculaturebrain microvesselsbrain vascular diseasebrain vascular dysfunctionbrain vascular pathologybrain vascular pathophysiologycapillarycardiac disease induced cognitive impairmentcentral nervous system plasticitycerebralcerebral angiopathycerebral microvasculaturecerebral microvesselscerebral vascularcerebral vascular diseasecerebral vascular dysfunctioncerebral vascular pathologycerebral vasculopathycerebro-vascularcerebrovascularcerebrovascular abnormalitycerebrovascular contribution to cognitive impairmentcerebrovascular contribution to cognitive impairment and dementiacerebrovascular contributions to cognitive dysfunctioncerebrovascular contributions to dementiacerebrovascular defectcerebrovascular disease pathologycerebrovascular dysfunctioncerebrovascular pathologycerebrovascular pathophysiologycerebrovasculopathycognitive dysfunctioncognitive lossdensitydisabilityendothelial dysfunctionfollowing menopausehealthy aginghealthy human aginghemodynamicshigh blood pressurehippocampalhippocampal atrophyhippocampal atropyhyperpiesiahyperpiesishypertensivehypertensive diseasehypertensive disorderhypoperfusionhypoxia/ischemiaimprovedin vivoinfarctinjuriesintracranial vascular dysfunctionischemia injuryischemic injurymalememory declinememory dysfunctionmid lifemid-lifemiddle agemiddle agedmidlifenatural agingneural plasticityneuro-vascularneuro-vascular couplingneuron injuryneuronalneuroplasticneuroplasticityneurovascularneurovascular abnormalityneurovascular couplingneurovascular dysregulationneurovascular impairmentneurovascular pathologyneurovasculopathynew drug targetnew druggable targetnew pharmacotherapy targetnew therapeutic targetnew therapy targetnormal agingnormative agingnormotensivenovelnovel drug targetnovel druggable targetnovel pharmacotherapy targetnovel therapeutic targetnovel therapy targetoxidative damageoxidative injurypast menopausepathophysiologypathwaypharmacologicpost-menopausalpostmenopausalpostmenopausal statuspressurepreventpreventingprotection pathwayprotective pathwayresponsesexsex based differencessex-dependent differencessex-related differencessex-specific differencessocial rolespontaneous hypertensive ratsubstantia albavascularvascular and cognitive impairmentvascular cognition impairmentvascular cognitive declinevascular cognitive diseasevascular cognitive disordervascular cognitive dysfunctionvascular cognitive impairment and dementiavascular cognitive impairment/dementiavascular contribution to impairment or dementiavascular contributions in dementiavascular contributions to cognition/dementiavascular contributions to cognitive declinevascular contributions to cognitive decline and dementiavascular contributions to cognitive impairmentvascular contributions to cognitive impairment and dementiavascular contributions to dementiavascular disease and impaired cognitionvascular dysfunction resulting in cognitive declinevascular related cognitive declinevascular related cognitive impairmentvascular related dementiavasopressorwhite matter
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Chronic hypertension affects over 100 million adults in the US and is a major risk factor for cerebrovascular
disease and vascular cognitive impairment (VCI). VCI involves impairment in multiple cognitive domains, often

affecting the hippocampus and memory function leading to dementia. The hippocampus is a deep brain structure

that is central to learning and memory and particularly susceptible to injury. Perfusion of the hippocampus is

maintained by small hippocampal arterioles (HAs) that are critical to both basal- and activity-dependent changes

in blood flow. Cognitive decline occurs more rapidly in the setting of chronic hypertension compared to normal

aging; however, how chronic hypertension and aging affect HAs remains unclear and could contribute to VCI.

The goal of this proposal is to investigate the novel role of HAs in healthy cognitive aging and VCI associated

with chronic hypertension. Our preliminary and published data show that HAs were hyperconstricted and had

impaired vasodilatory function in a rat model of chronic hypertension. Further, hippocampal perfusion was

significantly reduced and memory impaired during chronic hypertension that occurred as a function of age.

Importantly, HA dysfunction preceded these changes in perfusion and memory function, suggesting

hypertension-induced memory decline is vascular in nature. Our central hypothesis is that chronic hypertension

progressively decreases the vasodilatory function of HAs that reduces resting and activity-dependent changes

in hippocampal perfusion, resulting in neuronal injury and VCI. Aim 1 will investigate HA endothelial and vascular

smooth muscle function, including vasoconstrictive and vasodilatory pathways, in normotensive and

hypertensive rats by studying isolated and pressurized HAs in vitro. Circulating potent vasoconstrictors (e.g.

angiotensin II, endothelin-1, tumor necrosis factor alpha) that are elevated during chronic hypertension and

cause oxidative stress and damage endothelium will be investigated as underlying mechanisms by which chronic

hypertension causes hyperconstriction and impaired vasodilation of HAs. Aim 2 will investigate progressive

changes in hippocampal perfusion and neurovascular coupling – the innate ability of the brain to increase local

blood flow in response to neuronal activity – as it relates to neuronal function and memory in normotensive and

hypertensive rats across the lifetime. We will determine the role of HAs in age- and hypertension-induced

changes in hippocampal hemodynamics by investigating if therapeutically improving HA function prevents

perfusion deficits, protects hippocampal neurons and slows cognitive decline to be similar to normal aging. This

proposal will use both male and post-menopausal female rats to investigate sex differences in hypertension-

induced HA dysfunction, and whether one sex is more susceptible to age- or hypertension-induced changes in

hippocampal neurovascular function. The outcome of these studies will provide an understanding of the

involvement of the hippocampal vasculature in memory decline associated with normal aging, and how this may

be accelerated during chronic hypertension and contribute to VCI.

Grant Number: 5R01NS127284-05
NIH Institute/Center: NIH

Principal Investigator: Abbie Chapman

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →